Product Datasheet
|
|
| |
| Product Description |
| |
| Product: |
Human Thrombin Activatable Fibrinolysis Inhibitor |
| Catalog Number: |
TAFI |
| Product Page: |
https://www.mol-innov.com/products/IHUTAFI100UG |
| Description: |
Thrombin Activatable Fibrinolysis Inhibitor (TAFI), also known as plasma procarboxypeptidase-B and carboxypeptidase-U, is a single chain glycoprotein that is cleaved by thrombin, plasmin and trypsin. TAFI is purified from normal human plasma using immunoaffinity and ion-exchange chromatography. Activated TAFI cleaves C-terminal lysines on fibrin and cell surfaces resulting in down-regulation of fibrinolysis by reducing the number of plasminogen and tPA binding sites on fibrin. |
| Recommended Storage: |
SAMPLE |
| Minimum Shelf Life: |
418.00 |
| Source: |
5.0 mg/ml |
| Molecular Weight: |
Proteins |
| Extinction Coefficient: |
58,000 |
| Antigen: |
-70 C |
| Target: |
Frozen liquid |
| Target Molecular Weight: |
SERINE PROTEASE INHIBITORS |
| Host: |
2085.25 |
| Clonality: |
5 |
| Isotype: |
Human plasma |
| Applications: |
Dry ice |
| Cross-reactivity: |
3 years from delivery |
| Concentration: |
440 |
| Volume: |
2195 |
| Titer: |
0.02M Hepes; 0.2M NaCl; pH 7.4 |
| Buffer: |
SAMPLE |
| Form: |
0.1 mg |
| Preservative: |
0.05 ml |
| |
| Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
| |
| For in vitro laboratory use only |
| |
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |